Closed-loop Control of Glucose Levels After Meal Intake in Adults With Type 1 Diabetes
An Open-label, Randomized, Three-way, Cross-over Study to Compare the Efficacy of Closed-loop Operation Combined With Meal-and-carbohydrate-announcement Closed-loop Operation Combined With Meal-announcement, and Conventional Pump Therapy in Regulating Glucose Levels in Adults With Type 1 Diabetes
Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosage based on the sensor's readings. A dual-hormone closed-loop system would regulate glucose levels through the infusion of two hormones: insulin and glucagon.
The objective of this project is to assess whether a dual-hormone closed-loop strategy would alleviate the burden of carbohydrate counting from patients with type 1 diabetes (T1D) without a significant degradation in post-meal glucose control.
Our primary hypothesis is that meal-announcement strategy (pre-meal CHO-independent bolus) is equivalent to meal-and-carbohydrate-announcement strategy (full CHO-matching bolus) during closed-loop regulation of glucose levels in adults with T1D. Our secondary hypothesis is that closed-loop strategy with meal-announcement strategy (pre-meal CHO-independent bolus) or meal-and-carbohydrate-announcement strategy (full CHO-matching bolus) is better than conventional pump treatment in regulation of glucose levels in adults with T1D.
연구 개요
상세 설명
Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosages based on the sensor's readings. A dual-hormone closed-loop system would regulate glucose levels through the infusion of two hormone: insulin and glucagon.
Each patient will be admitted three times to a clinical research facility. In the meal-and-carbohydrate-announcement visit, patients will eat 3 meals accompanied with a matching insulin bolus (depending on the carbohydrate content of the meal) and glucose levels will be subsequently regulated using dual-hormone closed-loop system. In the meal-announcement visit, patients will eat the 3 same meals but will inject only a partial insulin bolus (not depending on carbohydrate content of the meal) and the remaining needed insulin will be delivered based on glucose sensor excursions as part of closed-loop operation. In the control visit, patients will use conventional pump therapy to regulate glucose levels.
연구 유형
등록 (실제)
단계
- 2 단계
연락처 및 위치
연구 장소
-
-
Quebec
-
Montreal, Quebec, 캐나다, H2W1R7
- Institut de recherches cliniques de Montreal
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Males and females ≥ 18 years of old.
- Clinical diagnosis of type 1 diabetes for at least one year.
- The subject will have been on insulin pump therapy for at least 3 months.
- Last (less than 3 months) HbA1c ≤ 12%.
Exclusion Criteria:
- Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator.
- Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
- Ongoing pregnancy.
- Severe hypoglycemic episode within two weeks of screening.
- Medication likely to affect with the interpretation of the results because of their well known impact on gastric emptying: Motilium®, Prandase®, Victoza®, Byetta® and Symlin®.
- Known or suspected allergy to the trial products, meal contents including nuts, peanuts, dairy products or eggs.
- Unusual nutritional habits (e.g. vegetarians)
- Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
- Failure to comply with team's recommendations (e.g. not willing to eat snack, not willing to change pump parameters, etc).
- Unreliable carbohydrate counting or lack of insulin to carbohydrate ratios
- Problems with venous access
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 크로스오버 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
활성 비교기: CHO-dependant bolus
An insulin bolus dependant of carbohydrate content will be given after each meal. Each subject insulin-to-carbohydrate ratio (U per 10g CHO) will be used to calculate the insulin bolus to be given. The dual-hormone closed-loop strategy will give the remaining insulin needed based on the sensor readings. |
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
|
활성 비교기: CHO-independent bolus
An insulin bolus independent of carbohydrate content will be given after each meal.
The dual-hormone closed-loop strategy will give the remaining insulin needed based on the sensor readings.
|
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
|
활성 비교기: Conventional treatment
Patients will use conventional pump therapy to regulate glucose levels
|
Subjects will be admitted at the IRCM at 6:30.
Subjects will be asked to fast from midnight.
At 8:00, a standardized (50g CHO for males; 30g CHO for females) meal will be served.
At 12:00, a standardized (120g CHO for males; 90g CHO for females) meal will be served.
At 17:00, a standardized (70g CHO for males; 50g CHO for females) meal will be served.
Between meals, patients will be allowed to do sedentary activities (reading, watching television, and playing video games, etc).
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The positive incremental area under the curve of postprandial glucose excursions
기간: 4 hours after meal intake
|
The positive incremental area under the curve (IAUC, as compared to pre-meal glucose value) of the 4-hr postprandial glucose excursions for the breakfast, lunch and dinner meals.
|
4 hours after meal intake
|
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
Mean plasma glucose
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Incremental two hours postprandial glucose
기간: 2 hours after meal intake
|
2 hours after meal intake
|
|
Incremental postprandial peak-glucose values
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Percentage of time of plasma glucose levels between 4.0 and 10.0 mmol/L
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Percentage of time of plasma glucose levels spent above 10.0 mmol/L
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Percentage of time of plasma glucose levels spent below 4.0 mmol/L
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Total insulin delivery
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Total glucagon delivery
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Standard deviation of glucose levels
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Percentage of time of plasma glucose concentrations below 3.5 mmol/L
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Percentage of time of plasma glucose concentrations above 14 mmol/L
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Mean plasma insulin concentration
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Mean plasma glucagon concentration
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Number of patients experiencing hypoglycemia requiring oral treatment
기간: 8h00 to 21h00
|
8h00 to 21h00
|
|
Incremental area under the curve of the 4-hr postprandial glucose excursions but the reference glucose is set to 5.0 mmol/L if premeal glucose is less than 5.0 mmol/L.
기간: 4 hours after meal intake
|
4 hours after meal intake
|
공동 작업자 및 조사자
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
제1형 당뇨병에 대한 임상 시험
-
Rhythm Pharmaceuticals, Inc.완전한Pro-opiomelanocortin(POMC), Proprotein Convertase Subtilisin/Kexin Type 1(PCSK1) 및 Leptin 수용체(LepR) 유전자 돌연변이미국, 이스라엘, 캐나다, 독일, 그리스, 이탈리아, 포르투갈
-
Duke Street Bio Ltd모병Advanced Malignancies With Homologous Recombination Deficiency (HRD) (Breast, Ovarian, mCRPC, Pancreatic Ductal Adenocarcinoma (PDAC), Brain Metastases)스페인, 프랑스, 헝가리, 미국
-
RevBioNational Institute on Aging (NIA)아직 모집하지 않음AO/OTA Type 2R3C 원위 요골 골절
-
Chong Kun Dang Pharmaceutical완전한
-
Salzburger LandesklinikenMedizinische Einrichtungen der Universität Düsseldorf; Universitätsklinkum Münster - Medizinische... 그리고 다른 협력자들모병
-
Sohag Universitysohag university hospital모병
-
University Hospital Hradec Kralove완전한
14 hours intervention에 대한 임상 시험
-
Shanghai Yueyang Integrated Medicine Hospital아직 모집하지 않음
-
Second Affiliated Hospital, School of Medicine,...모집하지 않고 적극적으로
-
Hospices Civils de Lyon아직 모집하지 않음
-
South China Normal University모집하지 않고 적극적으로
-
Guangzhou Women and Children's Medical Center아직 모집하지 않음NEC - 괴사성 장염
-
ICIM International S.r.l.아직 모집하지 않음
-
Monash UniversityThe Alfred; Melbourne Sexual Health Centre모병매독중국, 호주, 남아프리카, 영국